SEC 13F Intelligence

Skandinaviska Enskilda Banken AB (Publ) / LLY

Skandinaviska Enskilda Banken AB (Publ)’s Eli Lilly & Co Position

Does Skandinaviska Enskilda Banken AB (Publ) own Eli Lilly & Co (LLY)? Not currently — the last reported position was 347.7K shares worth $374M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$374M
Q4 2025
Shares
347.7K
% of Portfolio
+1.50%
Quarters Held
29
position exited

Position History LLY

Reported value by quarter
Q4 ’18: $44MQ4 ’18Q1 ’19: $57MQ2 ’19: $46MQ3 ’19: $48MQ4 ’19: $59MQ4 ’19Q1 ’20: $90MQ2 ’20: $106MQ3 ’20: $95MQ4 ’20: $91MQ4 ’20Q1 ’21: $103MQ2 ’21: $109MQ3 ’21: $112MQ4 ’21: $124MQ4 ’21Q1 ’22: $130MQ2 ’22: $149MQ3 ’22: $122MQ4 ’22: $136,548Q4 ’22Q1 ’23: $122,851Q2 ’23: $169,261Q3 ’23: $192,325Q4 ’23: $202MQ4 ’23Q1 ’24: $268MQ2 ’24: $303MQ3 ’24: $294MQ4 ’24: $260MQ4 ’24Q1 ’25: $265MQ2 ’25: $256MQ3 ’25: $274MQ4 ’25: $374MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2025347.7K$374M+1.50%
Q3 2025359.1K$274M+1.10%
Q2 2025329.0K$256M+1.12%
Q1 2025321.4K$265M+1.31%
Q4 2024336.6K$260M+1.18%
Q3 2024331.9K$294M+1.36%
Q2 2024334.3K$303M+1.45%
Q1 2024344.5K$268M+1.31%
Q4 2023346.4K$202M+1.17%
Q3 2023358.1K$192,325+1.26%
Q2 2023360.9K$169,261+1.11%
Q1 2023357.7K$122,851+0.86%
Q4 2022373.2K$136,548+1.03%
Q3 2022378.2K$122M+0.94%
Q2 2022460.7K$149M+1.10%
Q1 2022452.4K$130M+0.76%
Q4 2021447.1K$124M+0.64%
Q3 2021486.5K$112M+0.62%
Q2 2021475.4K$109M+0.67%
Q1 2021549.2K$103M+0.67%
Q4 2020536.4K$91M+0.62%
Q3 2020641.2K$95M+0.69%
Q2 2020644.2K$106M+0.85%
Q1 2020645.9K$90M+0.96%
Q4 2019449.0K$59M+0.46%
Q3 2019431.8K$48M+0.41%
Q2 2019412.1K$46M+0.39%
Q1 2019436.9K$57M+0.52%
Q4 2018376.9K$44M+0.39%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Skandinaviska Enskilda Banken AB (Publ)’s full portfolio or all institutional holders of LLY.